IMPACT OF MOLECULAR MARKERS ON THE OUTCOME OF ACUTE MYELOID LEUKEMIA WITH INTERMEDIATE-RISK CYTOGENETICS

被引：0
|
作者：
Hoyos, M. [1 ]
Brunet, S. [2 ]
Tormo, M. [2 ]
Ribera, J. M. [2 ]
Nomdedeu, J. [2 ]
Esteve, J. [2 ]
Llorente, A. [2 ]
Gallardo, D. [2 ]
Queipo de Llano, M. P. [2 ]
Duarte, R. [2 ]
Heras, I. [2 ]
Besalduch, J. [2 ]
Bargay, J. [2 ]
Marti, J. M. [2 ]
Pedro, C. [2 ]
Gonzalez, J. [2 ]
Font, L. [2 ]
Pratcorona, M. [2 ]
Oriol, A. [2 ]
Sierra, J. [2 ]
机构：
[1] Hosp Santa Creu & Sant Pau, Barcelona, Spain
[2] CET LAM Cooperat Grp, Barcelona, Spain
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2010年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0640
引用
收藏
页码：268 / 269
页数：2
相关论文
共 50 条
  • [31] Evaluation of pretreatment telomere length as a prognostic marker in intermediate-risk acute myeloid leukemia
    Gu, Runxia
    Cao, Jingjing
    Wei, Shuning
    Gong, Xiaoyuan
    Wang, Ying
    Mi, Yingchang
    Zhang, Junping
    Qiu, Shaowei
    Rao, Qing
    Wang, Min
    Wei, Hui
    Wang, Jianxiang
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2021, 43 (06) : 1510 - 1515
  • [32] A Risk Score Combined Clinical and Molecular Profiles Identifies a High-Risk Subgroup within Intermediate-Risk Acute Myeloid Leukemia
    Hu, Xiaoxia
    Huang, Aijie
    Chen, Qi
    Zhang, Ying
    Liu, Lixia
    Wang, Chengcheng
    Zhang, Weiping
    Yang, Jianmin
    BLOOD, 2019, 134
  • [33] Correlation of TET2 SNP rs2454206 with improved survival in children with acute myeloid leukemia featuring intermediate-risk cytogenetics
    Wang, Xingjuan
    Chen, Xi
    Yang, Zhenzhen
    Dou, Hu
    Lu, Ling
    Bi, Junqin
    Zou, Lin
    Yu, Jie
    Bao, Liming
    GENES CHROMOSOMES & CANCER, 2018, 57 (08): : 379 - 386
  • [34] Expression of indoleamine 2,3-dioxygenase in leukemic cells indicates an unfavorable prognosis in acute myeloid leukemia patients with intermediate-risk cytogenetics
    Fukuno, Kenji
    Hara, Takeshi
    Tsurumi, Hisashi
    Shibata, Yuhei
    Mabuchi, Ryoko
    Nakamura, Nobuhiko
    Kitagawa, Junichi
    Shimizu, Masahito
    Ito, Hiroyasu
    Saito, Kuniaki
    Moriwaki, Hisataka
    LEUKEMIA & LYMPHOMA, 2015, 56 (05) : 1398 - 1405
  • [35] Unfavorable-risk cytogenetics in acute myeloid leukemia
    Hong, Wan-Jen
    Medeiros, Bruno C.
    EXPERT REVIEW OF HEMATOLOGY, 2011, 4 (02) : 173 - 184
  • [36] A Focus on Intermediate-Risk Acute Myeloid Leukemia: Sub-Classification Updates and Therapeutic Challenges
    Awada, Hassan
    Ali, Moaath K. Mustafa
    Thapa, Bicky
    Awada, Hussein
    Seymour, Leroy
    Liu, Louisa
    Gurnari, Carmelo
    Kishtagari, Ashwin
    Wang, Eunice
    Baer, Maria R.
    CANCERS, 2022, 14 (17)
  • [37] Complete Molecular Risk Stratification of De Novo Acute Myeloid Leukemia with Intermediate Cytogenetics Using an Eight-Gene Panel
    Thangavelu, Maya
    Olson, Ryan
    Li, Li
    Ma, Wanlong
    Brodie, Steve
    Mixon, Chris
    Agersborg, Sally
    Wei, Eric
    Albitar, Maher
    BLOOD, 2014, 124 (21)
  • [38] The prognostic value of multilineage dysplasia in de novo acute myeloid leukemia patients with intermediate-risk cytogenetics is dependent on NPM1 mutational status
    Diaz-Beya, Marina
    Rozman, Maria
    Pratcorona, Marta
    Torrebadell, Montserrat
    Camos, Mireia
    Aguilar, Joseph L. I.
    Esteve, Jordi
    BLOOD, 2010, 116 (26) : 6147 - 6148
  • [39] The impact of genetic and molecular markers on therapeutic decisions in acute myeloid leukemia
    Hiddemann, W.
    Spiekermann, K.
    Buske, C.
    Feuringbuske, M.
    Braess, J.
    Haferlach, T.
    Schoch, C.
    Kern, W.
    Schnittger, S.
    Woermann, B.
    Heinecke, A.
    Sauerland, C.
    Buechner, T. H.
    ANNALS OF HEMATOLOGY, 2006, 85 : 75 - 77
  • [40] MicroRNA expression at diagnosis adds relevant prognostic information to molecular categorization in patients with intermediate-risk cytogenetic acute myeloid leukemia
    Diaz-Beya, M.
    Brunet, S.
    Nomdedeu, J.
    Tejero, R.
    Diaz, T.
    Pratcorona, M.
    Tormo, M.
    Ribera, J. M.
    Escoda, L.
    Duarte, R.
    Gallardo, D.
    Heras, I.
    de Llano, M. P. Queipo
    Bargay, J.
    Monzo, M.
    Sierra, J.
    Navarro, A.
    Esteve, J.
    LEUKEMIA, 2014, 28 (04) : 804 - 812
12345